These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11181840)

  • 1. Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs.
    Dazzi L; Spiga F; Pira L; Ladu S; Vacca G; Rivano A; Jentsch JD; Biggio G
    J Neurochem; 2001 Feb; 76(4):1212-20. PubMed ID: 11181840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with antidepressant drugs reduces the sensitivity of cortical cholinergic neurons to the activating actions of stress and the anxiogenic drug FG 7142.
    Dazzi L; Vacca G; Ladu S; Pisu MG; Serra M; Biggio G
    Neuropharmacology; 2001 Aug; 41(2):229-37. PubMed ID: 11489459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats.
    Dazzi L; Ladu S; Spiga F; Vacca G; Rivano A; Pira L; Biggio G
    Synapse; 2002 Jan; 43(1):70-7. PubMed ID: 11746735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs.
    Dazzi L; Serra M; Spiga F; Pisu MG; Jentsch JD; Biggio G
    Eur Neuropsychopharmacol; 2001 Oct; 11(5):343-9. PubMed ID: 11597820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of stress-induced dopamine output in the rat prefrontal cortex by chronic treatment with olanzapine.
    Dazzi L; Seu E; Cherchi G; Biggio G
    Biol Psychiatry; 2004 Mar; 55(5):477-83. PubMed ID: 15023575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine.
    Dazzi L; Seu E; Cherchi G; Biggio G
    Eur J Pharmacol; 2003 Aug; 476(1-2):55-61. PubMed ID: 12969749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142.
    Dazzi L; Vignone V; Seu E; Ladu S; Vacca G; Biggio G
    J Psychopharmacol; 2002 Jun; 16(2):125-31. PubMed ID: 12095070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.
    Dazzi L; Seu E; Cherchi G; Biggio G
    Eur Neuropsychopharmacol; 2005 May; 15(3):283-90. PubMed ID: 15820417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
    Nakayama K; Sakurai T; Katsu H
    Brain Res Bull; 2004 Apr; 63(3):237-41. PubMed ID: 15145142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex.
    Kamińska K; Gołembiowska K; Rogóż Z
    Pharmacol Rep; 2014 Dec; 66(6):984-90. PubMed ID: 25443725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex.
    Kamińska K; Górska A; Noworyta-Sokołowska K; Wojtas A; Rogóż Z; Gołembiowska K
    Pharmacol Rep; 2018 Oct; 70(5):1023-1031. PubMed ID: 30144663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.
    Masana M; Castañé A; Santana N; Bortolozzi A; Artigas F
    Neuropharmacology; 2012 Sep; 63(4):675-84. PubMed ID: 22652058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.
    Rogóz Z; Skuza G; Legutko B
    J Physiol Pharmacol; 2005 Dec; 56(4):661-71. PubMed ID: 16391422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine.
    Serra M; Pisul MG; Dazzi L; Purdy RH; Biggio G
    J Psychopharmacol; 2002 Jun; 16(2):133-8. PubMed ID: 12095071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of cortical allopregnanolone potentiates stress-induced increase in cortical dopamine output.
    Dazzi L; Serra M; Vacca G; Ladu S; Latrofa A; Trapani G; Biggio G
    Brain Res; 2002 Apr; 932(1-2):135-9. PubMed ID: 11911871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats.
    Matsumoto M; Yoshioka M; Togashi H; Mori K; Ueno K; Saito H
    Eur J Pharmacol; 1998 Feb; 343(2-3):165-70. PubMed ID: 9570464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.
    Yamamura S; Abe M; Nakagawa M; Ochi S; Ueno S; Okada M
    Neuropharmacology; 2011 Mar; 60(4):550-60. PubMed ID: 21195096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?
    Tanda G; Carboni E; Frau R; Di Chiara G
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):285-8. PubMed ID: 7862908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of a 'witness rat' to one treated with beta-carboline FG 7142 does not increase dopamine turnover in the medial prefrontal cortex of the 'witness rat'.
    Jaskiw GE; Lipska BK; Karoum F; Weinberger DR
    Neurosci Lett; 2001 Apr; 302(2-3):151-3. PubMed ID: 11290409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.